drugset / Trial / NCT01013675
Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly
RandomizedParallel-groupQuadruple-blindPrevention
Summary
A controlled, double-blind study to determine the immunogenicity and safety of influenza cell derived vaccine in elderly subjects.
Timeline
- Start
- 2009-11
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Influenza Virus Vaccine | Vaccine | 15 ug | — |
| Comparator | Influenza Virus Vaccine | Vaccine | 0.5 ml | — |
Indications
No indication recorded.